Maze Therapeutics earnings in focus as kidney drug rivalry heats up

Earnings call transcript: Westlake Chemical Partners tops Q3 2026 EPS forecast

Investing.com · News 12m ago

Intellia earnings loom: Can CRISPR biotech stabilize revenue?

Investing.com · News 12m ago

Iron Mountain earnings ahead as AI data center demand builds

Investing.com · News 13m ago

Eversource Energy earnings on deck after Q2 miss, estimate cuts

Investing.com · News 14m ago

Zoetis under pressure as earnings loom amid pet care headwinds

Investing.com · News 15m ago

Jefferies cuts Flutter Entertainment stock price target on FanDuel investment

Investing.com · News 17m ago

All eyes on PTC earnings amid pending Schneider acquisition

Investing.com · News 20m ago

LB Pharmaceuticals earnings loom with clinical trial progress in focus

Investing.com · News 21m ago

Gestamp 9M 2026 slides: margins expand despite flat revenue growth

Investing.com · News 22m ago

Global Payments earnings on deck as Worldpay synergies loom

Investing.com · News 22m ago